San Francisco Chronicle - September 30, 2004
Sabin Russell, srussell@sfchronicle.com.
A clinician who has been caring for AIDS patients at San Francisco General Hospital since 1982, McCune is also director of a lab within the Gladstone Institute of Virology and Immunology, located on the hospital campus.
McCune said he would use the money -- $500,000 a year for five years -- to carry out basic research in immunology. His studies will explore how the human body is able to suppress the AIDS virus for years and why that successful defense eventually breaks down.
The goal is to gain some insight that could lead to the design of an AIDS vaccine, either one that protects against infection by HIV or allows the body to live with it. Many species of monkeys are infected with SIV -- a viral cousin of HIV -- but are somehow able to suppress it and thus remain healthy.
He noted that results of AIDS vaccine research thus far had been dismal. "We need to go back to basics," said McCune. "We need to understand how to aim a vaccine before we shoot."
McCune is particularly intrigued about the role played by inflammation -- one of the body's natural defense mechanisms -- in promoting the progression of HIV infection.
Eight other researchers across the country will receive similar cash grants, which were announced by National Institutes of Health Director Dr. Elias Zerhouni. The winners are the first recipients of the NIH Director's Pioneer Award, a new program meant to encourage bold, innovative ideas that -- because they carry a high risk of failure -- would otherwise go unfunded.
McCune said the five-year duration of the grant provided enough time to allow researchers to thoroughly explore new ideas. Smaller grants might encourage innovation but are not sufficient to allow scientists to follow through on their hunches.
Although most of the Gladstone Institute researchers will be relocating shortly to a new building nearing completion that is adjacent to the UCSF campus at Mission Bay, McCune's lab will remain at San Francisco General.
040930
SC040913
Copyright © 2004 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com. http://www.sfgate.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .